SCHEMBL4875958

SCHEMBL4875958

CCCC(O)CCCCCCCCCCCCCC1CC(C)O1

nearest known ligand 0.42

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ TBXA2R P21731 1/20 0.39
▸ PTGFR P43088 1/20 0.39
▸ PTGER2 P43116 1/20 0.39
▸ DAGLA Q9Y4D2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ FFAR4 Q5NUL3 1/20 0.35
▸ FFAR1 O14842 1/20 0.35
▸ EPHX1 P07099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7194522 0.81 ALDH1A1 (0.59) TBXA2RPTGFRPTGER2DAGLAALDH1A1
SCHEMBL1110915 0.79 ALDH1A1 (0.35) ALDH1A1EPHX1
SCHEMBL4592154 0.78 EPHX1 (0.61) TBXA2RPTGFRPTGER2DAGLAALDH1A1
SCHEMBL1905959 0.78 DAGLA (0.43) DAGLAFFAR4
SCHEMBL1350844 0.78 EPHX1 (0.61) TBXA2RPTGFRPTGER2DAGLAALDH1A1
SCHEMBL1110951 0.75 ALDH1A1 (0.43) ALDH1A1EPHX1
SCHEMBL18662315 0.75 ALDH1A1 (0.43) ALDH1A1EPHX1
SCHEMBL1110980 0.75 ALDH1A1 (0.43) ALDH1A1EPHX1
SCHEMBL2049944 0.75 ALDH1A1 (0.43) ALDH1A1EPHX1
SCHEMBL8726836 0.74 ALDH1A1 (0.70) TBXA2RPTGFRPTGER2DAGLAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7316657-B2 Massage appliance with adjustable massage characteristics and storage container BEIERSDORF AG (DE) 2008-01-08 — — US disclosed
US-20050059914-A1 Massage appliance BEIERSDORF AG 2005-03-17 — — US disclosed
EP-0957927-B1 MEDICAL COMPOSITION AND USE THEREOF FOR THE MANUFACTURE OF A TOPICAL BARRIER FORMULATION, A UV-RADIATION ABSORBING FORMULATION, OR AN ANTIVIRAL, ANTIFUNGAL, OR ANTIINFLAMMATORY FORMULATION NOVISCENS AB (SE) 2005-02-09 — — EP disclosed
US-6562802-B2 Anionic ethylene amine scavenger; and cationic, hydrophilic amine containing polymer like chitosan and derivatives, cationic polyethylenes, DEAE-4, and polyornithine NOVISCENS AB (SE) 2003-05-13 — — US disclosed
US-20020128310-A1 MEDICAL COMPOSITION AND USE THEREOF FOR THE MANUFACTURE OF A TOPICAL BARRIER FORMULATION, A UV-RADIATION ABSORBING FORMULATION, OR AN ANTIVIRAL, ANTIFUNGAL, OR ANTIINFLAMMTORY FORMULATION NOVISCENS AB (SE) 2002-09-12 — — US disclosed
CN-1245431-A Medical composition and use thereof for manufacture of topical barrir formulation, UV-radiation absorbing formulation, or antiviral, antifungal, or antiinflammatory formulation NOVISCENS AB (SE) 2000-02-23 — — CN disclosed
EP-0957927-A1 MEDICAL COMPOSITION AND USE THEREOF FOR THE MANUFACTURE OF A TOPICAL BARRIER FORMULATION, A UV-RADIATION ABSORBING FORMULATION, OR AN ANTIVIRAL, ANTIFUNGAL, OR ANTIINFLAMMATORY FORMULATION Noviscens AB (SE) 1999-11-24 — — EP disclosed
WO-1998026788-A1 MEDICAL COMPOSITION AND USE THEREOF FOR THE MANUFACTURE OF A TOPICAL BARRIER FORMULATION, A UV-RADIATION ABSORBING FORMULATION, OR AN ANTIVIRAL, ANTIFUNGAL, OR ANTIINFLAMMATORY FORMULATION NOVISCENS AB (SE) 1998-06-25 — — WO disclosed
Send feedback